Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1968 1
1977 11
1978 11
1979 19
1980 19
1981 28
1982 24
1983 46
1984 33
1985 37
1986 44
1987 52
1988 58
1989 68
1990 69
1991 77
1992 62
1993 82
1994 77
1995 98
1996 177
1997 193
1998 172
1999 166
2000 206
2001 166
2002 227
2003 310
2004 249
2005 278
2006 302
2007 351
2008 329
2009 402
2010 402
2011 437
2012 523
2013 533
2014 514
2015 530
2016 495
2017 427
2018 488
2019 269
2020 15
Text availability
Article attribute
Article type
Publication date

Search Results

8,106 results
Results by year
Filters applied: . Clear all
Page 1
Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer.
Chi KN, Agarwal N, Bjartell A, Chung BH, Pereira de Santana Gomes AJ, Given R, Juárez Soto Á, Merseburger AS, Özgüroğlu M, Uemura H, Ye D, Deprince K, Naini V, Li J, Cheng S, Yu MK, Zhang K, Larsen JS, McCarthy S, Chowdhury S; TITAN Investigators. Chi KN, et al. N Engl J Med. 2019 Jul 4;381(1):13-24. doi: 10.1056/NEJMoa1903307. Epub 2019 May 31. N Engl J Med. 2019. PMID: 31150574 Clinical Trial.
Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology.
Nuhn P, De Bono JS, Fizazi K, Freedland SJ, Grilli M, Kantoff PW, Sonpavde G, Sternberg CN, Yegnasubramanian S, Antonarakis ES. Nuhn P, et al. Eur Urol. 2019 Jan;75(1):88-99. doi: 10.1016/j.eururo.2018.03.028. Epub 2018 Apr 16. Eur Urol. 2019. PMID: 29673712 Review.
Darolutamide (ODM-201) for the treatment of prostate cancer.
Shore ND. Shore ND. Expert Opin Pharmacother. 2017 Jun;18(9):945-952. doi: 10.1080/14656566.2017.1329820. Epub 2017 May 24. Expert Opin Pharmacother. 2017. PMID: 28490267 Review.
Apalutamide: A new agent in the management of prostate cancer.
May MB, Glode AE. May MB, et al. J Oncol Pharm Pract. 2019 Dec;25(8):1968-1978. doi: 10.1177/1078155219864424. Epub 2019 Jul 30. J Oncol Pharm Pract. 2019. PMID: 31359832 Review.
Transgender health: Hormonal management at 50 years and beyond.
Libby V, Lee M, Liu JH. Libby V, et al. Maturitas. 2019 Aug;126:34-37. doi: 10.1016/j.maturitas.2019.04.220. Epub 2019 May 1. Maturitas. 2019. PMID: 31239115 Review.
8,106 results
Jump to page
Feedback